Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis

Completed · Phase 3

Conditions studied: Plaque Psoriasis

In brief

The objective of this study is to evaluate the long-term safety of IDP-118 lotion.

Key facts

Study ID

NCT02462083

Run by

Bausch Health Americas, Inc.

People needed

555

Starts

2015-08-11

Expected to finish

2017-04-24

Last updated by the study team

2020-01-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Valeant Site 6 — Mobile, Alabama, United States
• Valeant Site 24 — Beverly Hills, California, United States
• Valeant Site 32 — Encinitas, California, United States
• Valeant Site 27 — Encino, California, United States
• Valeant Site 33 — Los Angeles, California, United States
• Valeant Site 43 — Los Angeles, California, United States
• Valeant Site 45 — Sacramento, California, United States
• Valeant Site 25 — San Diego, California, United States
• Valeant Site 4 — San Diego, California, United States
• Valeant Site 44 — Santa Monica, California, United States
• Valeant Site 36 — Santa Rosa, California, United States
• Valeant Site 10 — Englewood, Colorado, United States
• Valeant Site 3 — Boynton Beach, Florida, United States
• Valeant Site 28 — Coral Gables, Florida, United States
• Valeant Site 1 — Miami, Florida, United States
• Valeant Site 37 — North Miami Beach, Florida, United States
• Valeant Site 13 — Sanford, Florida, United States
• Valeant Site 41 — Snellville, Georgia, United States
• Valeant Site 17 — South Bend, Indiana, United States
• Valeant Site 12 — Olathe, Kansas, United States
• Valeant Site 19 — Louisville, Kentucky, United States
• Valeant Site 14 — Louisville, Kentucky, United States
• Valeant Site 35 — Clinton Township, Michigan, United States
• Valeant Site 34 — Detroit, Michigan, United States
• Valeant Site 16 — Warren, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.